利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

21 条记录 (耗时 0.016 秒)

    METHOD FOR PREPARING PRECURSOR USED FOR LABELING HEPATOCYTE RECEPTOR AND CONTAINING TRISACCHARIDE AND DTPA LIGAND
    2.
    发明申请
    METHOD FOR PREPARING PRECURSOR USED FOR LABELING HEPATOCYTE RECEPTOR AND CONTAINING TRISACCHARIDE AND DTPA LIGAND 有权
    制备用于标记肝细胞受体和含有TRISACCHARIDE和DTPA配体的前体的方法

    公开(公告)号：US20140046045A1

    公开(公告)日：2014-02-13

    申请号：US13571731

    申请日：2012-08-10

    申请人： CHIH-YUAN LIN ,  YU CHANG ,  JEN-TSUNG WANG ,  CHENG-FANG HSU ,  WEI-TI KUO ,  HUNG-WEN YU ,  WUU-JYH LIN ,  MEI-HUI WANG

    发明人： CHIH-YUAN LIN ,  YU CHANG ,  JEN-TSUNG WANG ,  CHENG-FANG HSU ,  WEI-TI KUO ,  HUNG-WEN YU ,  WUU-JYH LIN ,  MEI-HUI WANG

    IPC分类号： C07H15/04 ,  C07H1/06

    CPC分类号： C07H1/06 ,  C07H15/04 ,  C07K1/13

    摘要： A method for preparing a precursor used to label hepatocyte receptors is revealed. The precursor contains a bifunctional structure including trisaccharide and DTPA ligand. During synthesis processes of the precursor, silica gel columns and Reverse phase-18 (RP-18) columns are used for purification. Thus both the purification times and cost of each purification are reduced. Moreover, use diethyl ether to facilitate precipitation of products and remove a part of coupling reagent. Removing the coupling reagent helps purification of products. Furthermore, Nα,Nα-bis(carboxymethyl)-L-lysine hydrate and benzyl chloroformate are coupled to form a trisaccharide skeleton so as to ensure the yield rate of trisaccharide structure.

    摘要翻译： 揭示了制备用于标记肝细胞受体的前体的方法。 该前体含有包括三糖和DTPA配体的双功能结构。 在前体的合成过程中，使用硅胶柱和反相18（RP-18）柱进行纯化。 因此，每次纯化的纯化时间和成本均降低。 此外，使用乙醚促进产物沉淀并除去一部分偶联剂。 去除偶联剂有助于净化产品。 此外，Nalpha，Nalpha-双（羧甲基）-L-赖氨酸水合物和氯甲酸苄酯偶联形成三糖骨架，以确保三糖结构的产率。

    Bifunctional compound containing amino group and diaminedithiol ligand and manufacturing method thereof
    3.
    发明授权
    Bifunctional compound containing amino group and diaminedithiol ligand and manufacturing method thereof 有权
    含有氨基和二硫代二醇配体的双官能化合物及其制备方法

    公开(公告)号：US07964752B2

    公开(公告)日：2011-06-21

    申请号：US12540467

    申请日：2009-08-13

    申请人： Show-Wen Liu ,  Cheng-Hsien Lin ,  Tsyh-Lang Lin ,  Cheng-Fang Hsu

    发明人： Show-Wen Liu ,  Cheng-Hsien Lin ,  Tsyh-Lang Lin ,  Cheng-Fang Hsu

    IPC分类号： C07C233/05 ,  C07C237/10

    CPC分类号： C07C323/41 ,  Y02P20/55

    摘要： A bifunctional compound containing an amino group and diaminedithiol ligand and a manufacturing method thereof are revealed, the bifunctional compound includes at least one amino group and a diaminedithiol (N2S2) ligand. The amino groups is for reacting with compounds containing carboxylic acids or halogens while the N2S2 ligand binds with technetium or rhenium so as to form an anion complex. The thiol group in the N2S2 ligand is protected by a protecting group for prevention of oxidation and easy storage. This protecting group is released easily during complex reactions. Due to the bifunctional property, the compound is applied to preparation of radiopharmaceuticals such as imaging agents and targeted agents.

    摘要翻译： 显示含有氨基和二硫代二醇配体的双官能化合物及其制备方法，双官能化合物包括至少一个氨基和二硫代二醇（N 2 S 2）配体。 氨基用于与含有羧酸或卤素的化合物反应，而N2S2配体与锝或铼结合形成阴离子络合物。 N2S2配体中的硫醇基团被保护基团保护，以防止氧化和容易储存。 这种保护基团在复杂的反应过程中容易释放。 由于双功能性，该化合物被用于制备放射性药物如成像剂和靶向剂。

    BIFUNCTIONAL COMPOUND WITH MONOSACCHARIDE AND N2S2 LIGAND, AND PREPARATION AND USE THEREOF
    5.
    发明申请
    BIFUNCTIONAL COMPOUND WITH MONOSACCHARIDE AND N2S2 LIGAND, AND PREPARATION AND USE THEREOF 有权
    具有单糖和N2S2配体的双功能化合物，其制备和使用

    公开(公告)号：US20120009669A1

    公开(公告)日：2012-01-12

    申请号：US13087664

    申请日：2011-04-15

    申请人： SHOW-WEN LIU ,  CHENG-HSIEN LIN ,  YU CHANG ,  CHENG-FANG HSU ,  TSYH-LANG LIN

    发明人： SHOW-WEN LIU ,  CHENG-HSIEN LIN ,  YU CHANG ,  CHENG-FANG HSU ,  TSYH-LANG LIN

    IPC分类号： C07H15/04 ,  C12N5/071 ,  C07K14/00

    CPC分类号： C07H15/04

    摘要： A bifunctional compound with a monosaccharide and a N2S2 ligand, and more particularly, a bifunctional compound with a N2S2 ligand and aminohexylacetyl galactosamine (ah-GalNAc4) is provided. A method for preparing the bifunctional compound with a monosaccharide and a N2S2 ligand is also provided, including activating a carboxyl group in an organic ligand, reacting the activated carboxyl group with a galactopyranoside through amidation, and then hydrolyzing. The bifunctional compound of the present invention is widely useful in nuclear medicine for preparation of liver imaging agents for assisting in correct diagnosis of diseases.

    摘要翻译： 提供了具有单糖和N2S2配体的双官能化合物，更具体地，提供了具有N 2 S 2配体和氨基己基乙酰基半乳糖胺（ah-GalNAc 4）的双官能化合物。 还提供了用单糖和N 2 S 2配体制备双功能化合物的方法，包括活化有机配体中的羧基，通过酰胺化使活化的羧基与吡喃半乳糖苷反应，然后水解。 本发明的双功能化合物在制备用于辅助正确诊断疾病的肝成像剂的核医学中广泛有用。

    Method for preparing precursor of radioactive 3-iodobenzylguanidine
    7.
    发明授权
    Method for preparing precursor of radioactive 3-iodobenzylguanidine 有权
    制备放射性3-碘苄基胍前体的方法

    公开(公告)号：US08076499B2

    公开(公告)日：2011-12-13

    申请号：US12540448

    申请日：2009-08-13

    申请人： Show-Wen Liu ,  Cheng-Hsien Lin ,  Tsyh-Lang Lin ,  Cheng-Fang Hsu

    发明人： Show-Wen Liu ,  Cheng-Hsien Lin ,  Tsyh-Lang Lin ,  Cheng-Fang Hsu

    IPC分类号： C07F3/10 ,  C07F7/00

    CPC分类号： C07C277/08 ,  C07B2200/05 ,  C07C279/06

    摘要： A method for preparing a precursor of radioactive 3-iodobenzylguanidine- N,N′-bis(tert-butyloxycarbonyl)-3-(tri-n-butyltin)benzylguanidine) (MSnBG) is revealed. The method includes following steps. Firstly, obtain 3-iodobenzylguanidine bicarbonate by an addition reaction between 3-iodobenzylamine hydrochloride and cyanamide. Use di-tert-butyl dicarbonate as a protecting agent for NH group and convert 3-iodobenzylguanidine bicarbonate into N,N′-bis(tert-butyloxycarbonyl)-N-(3-iodobenzyl) guanidine. At last, under catalysis of bis(triphenylphosphine) palladium dichloride, obtain a final product MSnBG by a substitution reaction between N,N′-bis(tert-butyloxycarbonyl)-N-(3-iodobenzyl) guanidine and bis(tri-n-butyltin). MSnBG is used in no-carrier-added synthesis of [*l]MIBG.

    摘要翻译： 揭示了制备放射性3-碘苄基胍-N，N'-双（叔丁氧基羰基）-3-（三正丁基锡）苄基胍）前体的方法（MSnBG）。 该方法包括以下步骤。 首先，通过3-碘苄胺盐酸盐和氨腈之间的加成反应获得3-碘苄基胍碳酸氢盐。 使用二碳酸二叔丁酯作为NH基团的保护剂，并将3-碘苄基胍碳酸氢盐转化成N，N'-双（叔丁氧基羰基）-N-（3-碘苄基）胍。 最后，在双（三苯基膦）二氯化钯的催化下，通过N，N'-双（叔丁氧基羰基）-N-（3-碘苄基）胍与双（三正丁基）二氯化钯的取代反应得到最终产物MSnBG， 丁基锡）。 MSnBG用于[* 1] MIBG的无载体添加合成。

    Compound containing carboxylate ester and N2S2 ligand bi-functional groups and manufacturing method thereof
    8.
    发明授权
    Compound containing carboxylate ester and N2S2 ligand bi-functional groups and manufacturing method thereof 有权
    含羧酸酯和N2S2配位体双官能团的化合物及其制备方法

    公开(公告)号：US07935833B2

    公开(公告)日：2011-05-03

    申请号：US12203214

    申请日：2008-09-03

    申请人： Show-Wen Liu ,  Tsyh-Lang Lin ,  Cheng-Fang Hsu ,  Cheng-Hsien Lin ,  Tsai-Yueh Luo ,  Lie-Hang Shen ,  Haw-Jan Chen

    发明人： Show-Wen Liu ,  Tsyh-Lang Lin ,  Cheng-Fang Hsu ,  Cheng-Hsien Lin ,  Tsai-Yueh Luo ,  Lie-Hang Shen ,  Haw-Jan Chen

    IPC分类号： C07D207/46

    CPC分类号： C07D207/46 ,  Y02P20/55

    摘要： A compound containing carboxylate ester and N2S2 ligand bi-functional groups and a manufacturing method thereof are disclosed. The S in the N2S2 ligand of the compound containing carboxylate ester and N2S2 ligand bi-functional groups includes a protective group so as to avoid to be oxidized and easy storage. In a complex reaction, the protective group is automatically released As to the active carboxylate ester, it is for reacting with compounds having amino groups such as amines, amino acids, peptides, or protein etc while the N2S2 ligand is for bonding with technetium or rhenium so as to form neutral complex. The compound containing carboxylate ester and N2S2 ligand bi-functional groups is applied to radiopharmaceuticals such as contrast agents for tissues and target agents.

    摘要翻译： 公开了含有羧酸酯和N 2 S 2配位体双官能团的化合物及其制备方法。 含有羧酸酯和N2S2配位体双官能团的化合物的N2S2配体中的S包括保护基，以避免被氧化并容易储存。 在复杂的反应中，保护基被自动释放对于活性羧酸酯，它是与具有氨基的化合物如胺，氨基酸，肽或蛋白质等反应，而N2S2配体与锝或铼键合 从而形成中性复合物。 含有羧酸酯和N 2 S 2配位体双功能基团的化合物被应用于放射性药物，例如用于组织和靶标的造影剂。

    METHOD FOR PREPARING PRECURSOR OF RADIOACTIVE 3-IODOBENZYLGUANIDINE
    9.
    发明申请
    METHOD FOR PREPARING PRECURSOR OF RADIOACTIVE 3-IODOBENZYLGUANIDINE 有权
    放射性3-碘代乙酰胺前体的制备方法

    公开(公告)号：US20110040119A1

    公开(公告)日：2011-02-17

    申请号：US12540448

    申请日：2009-08-13

    申请人： Show-Wen LIU ,  Cheng-Hsien Lin ,  Tsyh-Lang Lin ,  Cheng-Fang Hsu

    发明人： Show-Wen LIU ,  Cheng-Hsien Lin ,  Tsyh-Lang Lin ,  Cheng-Fang Hsu

    IPC分类号： C07C271/20

    CPC分类号： C07C277/08 ,  C07B2200/05 ,  C07C279/06

    摘要： A method for preparing a precursor of radioactive 3-iodobenzylguanidine-N,N′-bis(tert-butyloxycarbonyl)-3-(tri-n-butyltin)benzylguanidine) (MSnBG) is revealed. The MSnBG is a precursor of [*I]MIBG that is used as radioactive imaging agents and antineoplastic drugs. The method includes following steps. Firstly, obtain 3-iodobenzylguanidine bicarbonate by an addition reaction between 3-iodobenzylamine hydrochloride and cyanamide. Use di-tert-butyl dicarbonate as a protecting agent for NH group and convert 3-iodobenzylguanidine bicarbonate into N,N′-bis(tert-butyloxycarbonyl)-N-(3-iodobenzyl) guanidine. At last, under catalysis of bis(triphenylphosphine) palladium dichloride, obtain a final product MSnBG by a substitution reaction between N,N′-bis(tert-butyloxycarbonyl)-N-(3-iodobenzyl) guanidine and bis(tri-n-butyltin). MSnBG is used in no-carrier-added synthesis of [*I]MIBG. The [*I]MIBG obtained by this method has better effect on neuroblastoma treatment than that obtained by conventional, carrier-added method.

    摘要翻译： 揭示了制备放射性3-碘苄基胍-N，N'-双（叔丁氧基羰基）-3-（三正丁基锡）苄基胍）（MSnBG）的前体的方法。 MSnBG是用作放射性成像剂和抗肿瘤药物的[* I] MIBG的前体。 该方法包括以下步骤。 首先，通过3-碘苄胺盐酸盐和氨腈之间的加成反应获得3-碘苄基胍碳酸氢盐。 使用二碳酸二叔丁酯作为NH基团的保护剂，并将3-碘苄基胍碳酸氢盐转化成N，N'-双（叔丁氧基羰基）-N-（3-碘苄基）胍。 最后，在双（三苯基膦）二氯化钯的催化下，通过N，N'-双（叔丁氧基羰基）-N-（3-碘苄基）胍与双（三正丁基）二氯化钯的取代反应得到最终产物MSnBG， 丁基锡）。 MSnBG用于[* I] MIBG的无载体添加合成。 通过该方法获得的[* I] MIBG对于神经母细胞瘤治疗比通过常规的载体添加方法获得的效果更好。

    RADIOACTIVE MIXTURE AND MANUFACTURING METHOD THEREOF
    10.
    发明申请
    RADIOACTIVE MIXTURE AND MANUFACTURING METHOD THEREOF 有权
    放射性混合物及其制造方法

    公开(公告)号：US20100183508A1

    公开(公告)日：2010-07-22

    申请号：US12354815

    申请日：2009-01-16

    申请人： Tsai-Yueh LUO ,  I-Chung Tang ,  Show-Wen Liu ,  Yu-Lung Wu ,  Cheng-Hsien Lin ,  Cheng-Fang Hsu ,  Kwei-Luen Hsu ,  Chang-Mau Sheng ,  Ching-Jun Liou ,  Te-Sheng Liang

    发明人： Tsai-Yueh LUO ,  I-Chung Tang ,  Show-Wen Liu ,  Yu-Lung Wu ,  Cheng-Hsien Lin ,  Cheng-Fang Hsu ,  Kwei-Luen Hsu ,  Chang-Mau Sheng ,  Ching-Jun Liou ,  Te-Sheng Liang

    IPC分类号： A61K51/04 ,  A61P35/00

    CPC分类号： A61K51/0478 ,  A61K49/0438

    摘要： A radioactive mixture and a manufacturing method thereof are disclosed. The radioactive mixture (188Re-MN/Lipiodol mixture) is formed by chelating reaction of MN series compounds that are amine-amide-disulfide amine quadric-dentate chelate ligands with TcO4−/or ReO4−, and then dissolved in Lipiodol. Moreover, the 99mTc/or 188Re of the TcO4−/or ReO4− avoids bone marrow injuries caused by free 90Y. By the feature of the Lipiodol that stays in liver tumors for a long period, the radioactive mixture is applied to treat liver cancers by injection so that injuries caused by surgical operations can be prevented. 188Re-MN/Lipiodol is used for liver cancer, breast cancer or other solid tumors treatment. Re-188 MN or Re-188 MN/Lipiodol can be mixed with anticancer drugs, hydrogel, liposome, micelle or other nano-particles to form the multifunctional therapeutic modality.

    摘要翻译： 公开了放射性混合物及其制造方法。 通过胺胺 - 二硫化胺胺二齿螯合配体的MN系列化合物与TcO4-或ReO4-螯合反应形成放射性混合物（188Re-MN / Lipiodol混合物），然后溶解于Lipiodol中。 此外，TcO4- /或ReO4的99mTc /或188Re避免了由自由90Y引起的骨髓损伤。 通过长时间停留在肝肿瘤中的碘碘醇的特征，通过注射施用放射性混合物来治疗肝癌，从而可以预防外科手术引起的损伤。 188Re-MN / Lipiodol用于肝癌，乳腺癌或其他实体瘤治疗。 Re-188 MN或Re-188 MN / Lipiodol可与抗癌药物，水凝胶，脂质体，胶束或其他纳米颗粒混合，形成多功能治疗方式。